Skip to main content

Puma Biotechnology, Inc.

PBYI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001401667

In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in Puma Biotechnology, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
89
−13 vs. Q1 2022
Shares held
27.9M
−1.64M (−5.6%) vs. Q1 2022
Total value
$79.5M
−$5.45M (−6.4%) vs. Q1 2022
New holders
17
20 more added
Sold out
30
34 more reduced

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PBYI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 89 institutions
Q1 2021: 118 institutionsQ2 2021: 120 institutionsQ3 2021: 116 institutionsQ4 2021: 102 institutionsQ1 2022: 104 institutionsQ2 2022: 89 institutionsQ3 2022: 83 institutionsQ4 2022: 89 institutionsQ1 2023: 78 institutionsQ2 2023: 68 institutionsQ3 2023: 69 institutionsQ4 2023: 82 institutionsQ1 2024: 93 institutionsQ2 2024: 99 institutionsQ3 2024: 100 institutionsQ4 2024: 112 institutionsQ1 2025: 116 institutionsQ2 2025: 121 institutionsQ3 2025: 132 institutionsQ4 2025: 151 institutionsQ1 2026: 157 institutionsQ2 2026: 160 institutions
Value heldQ2 2022: $79.5M
Q1 2021: $355.9MQ2 2021: $319.3MQ3 2021: $226.0MQ4 2021: $93.1MQ1 2022: $86.1MQ2 2022: $79.5MQ3 2022: $65.5MQ4 2022: $116.3MQ1 2023: $86.3MQ2 2023: $93.8MQ3 2023: $67.6MQ4 2023: $117.0MQ1 2024: $164.4MQ2 2024: $101.0MQ3 2024: $76.0MQ4 2024: $90.1MQ1 2025: $90.1MQ2 2025: $112.8MQ3 2025: $182.6MQ4 2025: $210.2MQ1 2026: $241.8MQ2 2026: $313.6M
Institutions holding PBYI and their total value by quarter
QuarterHoldersValue
Q2 2026160$313.6M
Q1 2026157$241.8M
Q4 2025151$210.2M
Q3 2025132$182.6M
Q2 2025121$112.8M
Q1 2025116$90.1M
Q4 2024112$90.1M
Q3 2024100$76.0M
Q2 202499$101.0M
Q1 202493$164.4M
Q4 202382$117.0M
Q3 202369$67.6M
Q2 202368$93.8M
Q1 202378$86.3M
Q4 202289$116.3M
Q3 202283$65.5M
Q2 202289$79.5M
Q1 2022104$86.1M
Q4 2021102$93.1M
Q3 2021116$226.0M
Q2 2021120$319.3M
Q1 2021118$355.9M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Puma Biotechnology, Inc.; share changes are against Q1 2022.

Institutions holding PBYI in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Jump Financial, LLC0$00.00%−39,700−100.0%Sold out
Rhumbline Advisers0$00.00%−38,775−100.0%Sold out
Principal Financial Group Inc0$00.00%−33,483−100.0%Sold out
Pitcairn Co0$00.00%−27,558−100.0%Sold out
Mirabella Financial Services LLP0$00.00%−25,500−100.0%Sold out
State Board of Administration of Florida Retirement System0$00.00%−21,925−100.0%Sold out
Deutsche Bank AG0$00.00%−18,476−100.0%Sold out
American International Group, Inc.0$00.00%−16,026−100.0%Sold out
California State Teachers Retirement System0$00.00%−14,189−100.0%Sold out
Invesco Ltd.0$00.00%−11,855−100.0%Sold out
ProShare Advisors LLC0$00.00%−10,284−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−10,077−100.0%Sold out
Amalgamated Bank0$00.00%−5,256−100.0%Sold out
Legal & General Group Plc0$00.00%−3,554−100.0%Sold out
Royal Bank of Canada0$00.00%−3,044−100.0%Sold out
Ameritas Investment Partners, Inc.0$00.00%−2,522−100.0%Sold out
Meeder Asset Management Inc0$00.00%−2,078−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−600−100.0%Sold out
CWM, LLC0$00.00%−57−100.0%Sold out
Parametric Portfolio Associates LLC––––Not filed
Amalgamated Financial Corp.––––Not filed